methylprednisolone has been researched along with leflunomide in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gotoh, K; Hayashi, S; Inazu, M; Inoue, T; Ogawa, T | 1 |
| Assimakopoulos, D; Bai, M; Drosos, AA; Papazisi, D; Voulgari, PV; Zagorianakou, P | 1 |
| Hagiyama, H; Harigai, M; Iwai, H; Miyasaka, N; Mizoguchi, F; Ochi, S; Oka, T | 1 |
| Guo, G; Jian, X; Li, X; Lin, D; Ruan, Y | 1 |
| Carloni, A; Giannakakis, K; Nori, G; Piciucchi, S; Poletti, V; Zobel, BB | 1 |
| Bao, X; Cai, Y; Cao, L; Xie, L | 1 |
| Chen, YZ; Mei, CL; Wu, J; Zhao, XZ | 1 |
| Haroon, M; O'Gradaigh, D | 1 |
| Gučev, F; Hočevar, A; Marolt, VF; Perdan-Pirkmajer, K; Rotar, Ž; Tomšič, M; Žibert, J | 1 |
| Biswas, M; Chatterjee, S; Ghosh, A; Ghosh, S; Sarkate, P | 1 |
| Fang, JP; Ou, RQ; Tan, WP; Wang, HY; Wu, BJ; Xu, LH | 1 |
| Ding, J; Li, Y; Su, B; Wang, F; Wang, S; Xiao, H; Xu, K; Zhang, L; Zhong, X | 1 |
| Hingorani, A; Jaikaran, O; Nicoara, M | 1 |
| Cai, S; Dong, L; Li, M; Sun, W | 1 |
| Cui, S; Li, P; Li, Q; Li, W; Shang, S; Wang, C; Wang, W | 1 |
| Jiang, F; Liu, H; Xing, X; Zhang, M; Zheng, K; Zhou, C | 1 |
4 review(s) available for methylprednisolone and leflunomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Laryngeal involvement in rheumatoid arthritis.
Topics: Aged; Anti-Inflammatory Agents; Arytenoid Cartilage; Cricoid Cartilage; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Joints; Laryngeal Diseases; Leflunomide; Methylprednisolone; Prednisone; Rheumatoid Nodule; Treatment Outcome | 2005 |
Combination regimen of leflunomide plus methylprednisolone in a female patient with reactive arthritis and concomitant IgA nephropathy.
Topics: Adolescent; Adult; Arthritis, Reactive; Drug Combinations; Female; Glomerulonephritis, IGA; Humans; Isoxazoles; Leflunomide; Male; Methylprednisolone; Young Adult | 2010 |
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Aspergillosis; Aspergillus fumigatus; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Cytokine Release Syndrome; Deprescriptions; Disease Progression; Dyspnea; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; Interleukin-6; Leflunomide; Lung; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Oxygen Inhalation Therapy; Pandemics; Pneumocystis carinii; Pneumonia, Pneumocystis; Pneumonia, Viral; Pulmonary Aspergillosis; Recurrence; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
1 trial(s) available for methylprednisolone and leflunomide
| Article | Year |
|---|---|
Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Injections, Intra-Articular; Isoxazoles; Knee Joint; Leflunomide; Male; Methylprednisolone; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Secondary Prevention; Tumor Necrosis Factor-alpha | 2010 |
16 other study(ies) available for methylprednisolone and leflunomide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Azathioprine; Basement Membrane; Body Weight; Cholesterol; Fibrinogen; Glomerulonephritis; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Kidney Glomerulus; Leflunomide; Male; Methylprednisolone; Methylprednisolone Acetate; Proteinuria; Rabbits; Rats; Rats, Inbred Strains | 1991 |
Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Cholestyramine Resin; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methylprednisolone; Pulmonary Alveoli; Tomography, X-Ray Computed | 2006 |
Severe cutaneous adverse drug reaction to leflunomide: a report of two cases.
Topics: Adolescent; Anti-Inflammatory Agents; Blister; Drug Eruptions; Exanthema; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Severity of Illness Index; Sjogren's Syndrome; Treatment Outcome | 2008 |
Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Dyspnea; Hemoptysis; Hemorrhage; Humans; Isoxazoles; Kidney; Leflunomide; Lung; Lung Diseases; Male; Methylprednisolone; Muscle Weakness; Pleural Effusion; Pulmonary Alveoli; Tomography, X-Ray Computed | 2008 |
Leflunomide for the successful management of juvenile Cogan's syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Child; Cogan Syndrome; Drug Therapy, Combination; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Male; Methylprednisolone; Prednisolone; Remission Induction; Treatment Outcome | 2009 |
Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Methylprednisolone; Registries; Slovenia; Sulfasalazine; Tumor Necrosis Factor-alpha | 2013 |
Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Methylprednisolone; Middle Aged; Severity of Illness Index; Sulfasalazine; Triglycerides; Young Adult | 2013 |
Corticosteroid in Combination with Leflunomide and Mesenchymal Stem Cells for Treatment of Pediatric Idiopathic Pulmonary Hemosiderosis.
Topics: Adrenal Cortex Hormones; Child; Female; Glucocorticoids; Hemosiderosis; Hemosiderosis, Pulmonary; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Diseases; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methylprednisolone; Prednisone; Pulse Therapy, Drug; Retrospective Studies; Treatment Outcome | 2017 |
Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Atrophy; Biopsy; Child; Child, Preschool; Cyclophosphamide; Female; Fibrosis; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immunosuppressive Agents; Kidney Tubules; Leflunomide; Male; Methylprednisolone; Mycophenolic Acid; Proteinuria; Risk Factors | 2018 |
Noninfectious aortitis: A case report.
Topics: Abdominal Pain; Aged; Aortitis; Back Pain; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Male; Methylprednisolone; Treatment Outcome | 2020 |
Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy.
Topics: Creatinine; Diabetic Nephropathies; Drug Therapy, Combination; Glomerulonephritis, Membranous; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Leflunomide; Methylprednisolone; Retrospective Studies; Serum Albumin | 2022 |
Clinical Effect of Lamivudine Combined with Leflunomide and Methylprednisolone Tablets in the Treatment of Hepatitis B Virus-Associated Glomerulonephritis and Its Influence on Renal Function Indicators.
Topics: Glomerulonephritis; Hepatitis B virus; Humans; Interleukin-4; Kidney; Lamivudine; Leflunomide; Methylprednisolone; Retrospective Studies; Tablets | 2023 |